These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7678439)

  • 1. Finasteride for benign prostatic hyperplasia.
    DuBeau CE
    N Engl J Med; 1993 Feb; 328(6):443. PubMed ID: 7678439
    [No Abstract]   [Full Text] [Related]  

  • 2. New options for patients with benign prostatic hyperplasia.
    Ellenberger B
    CMAJ; 1993 Feb; 148(4):543-7. PubMed ID: 7679313
    [No Abstract]   [Full Text] [Related]  

  • 3. Finasteride for benign prostatic hyperplasia.
    Hasinski S; Miller JL; Rose LI
    Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finasteride for benign prostatic hyperplasia.
    Geller DM
    N Engl J Med; 1993 Feb; 328(6):442-3. PubMed ID: 7678437
    [No Abstract]   [Full Text] [Related]  

  • 5. Thoughts on finasteride for benign prostatic hyperplasia.
    Anand A
    Am Fam Physician; 1993 Sep; 48(4):582, 588. PubMed ID: 7691035
    [No Abstract]   [Full Text] [Related]  

  • 6. Finasteride for benign prostatic hypertrophy.
    Med Lett Drugs Ther; 1992 Sep; 34(878):83-4. PubMed ID: 1380630
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term urodynamic effects of finasteride in benign prostatic hyperplasia: a pilot study.
    Kirby RS; Vale J; Bryan J; Holmes K; Webb JA
    Eur Urol; 1993; 24(1):20-6. PubMed ID: 7689971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride: a 5 alpha-reductase inhibitor.
    Steiner JF
    Clin Pharm; 1993 Jan; 12(1):15-23. PubMed ID: 7679063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-alpha reductase inhibitor in prostatic adenoma?].
    Heinzl S
    Med Monatsschr Pharm; 1990 Dec; 13(12):382-4. PubMed ID: 1705307
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical treatment of benign prostatic hyperplasia.
    Schmidt JD
    West J Med; 1991 Dec; 155(6):633. PubMed ID: 1725942
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the prostate pill finally here?
    Lange PH
    N Engl J Med; 1992 Oct; 327(17):1234-6. PubMed ID: 1383817
    [No Abstract]   [Full Text] [Related]  

  • 13. Finasteride for benign prostatic hyperplasia.
    Holdcroft C
    Nurse Pract; 1993 Mar; 18(3):57-8. PubMed ID: 7681553
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of finasteride in men with benign prostatic hyperplasia.
    Walsh PC
    J Urol; 1993 Apr; 149(4):932-3. PubMed ID: 7681121
    [No Abstract]   [Full Text] [Related]  

  • 15. Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic evaluation.
    Kirby RS; Bryan J; Eardley I; Christmas TJ; Liu S; Holmes SA; Vale JA; Shanmuganathan K; Webb JA
    Br J Urol; 1992 Jul; 70(1):65-72. PubMed ID: 1379107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic adenoma: new drugs, new surgical techniques].
    Heinzl S
    Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
    Stoner E
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):375-8. PubMed ID: 1701660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long term treatment with finasteride (MK-906), a 5-alpha reductase inhibitor, on circulating LH, FSH, prolactin and estradiol.
    Matzkin H; Chen J; Lewyshon O; Ayalon D; Braf Z
    Horm Metab Res; 1992 Oct; 24(10):498-9. PubMed ID: 1281461
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.
    Serio M; Fiorelli G
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):C77-81. PubMed ID: 1718792
    [No Abstract]   [Full Text] [Related]  

  • 20. Finasteride: the first 5 alpha-reductase inhibitor.
    Sudduth SL; Koronkowski MJ
    Pharmacotherapy; 1993; 13(4):309-25; discussion 325-9. PubMed ID: 7689728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.